Treatt (TET) Competitors GBX 506 +4.00 (+0.80%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades TET vs. ELM, VCT, ESNT, SCPA, SYNT, ZTF, IOF, WCH, ITX, and DCTAShould you be buying Treatt stock or one of its competitors? The main competitors of Treatt include Elementis (ELM), Victrex (VCT), Essentra (ESNT), Scapa Group (SCPA), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry. Treatt vs. Elementis Victrex Essentra Scapa Group Synthomer Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Elementis (LON:ELM) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk. Which has stronger earnings & valuation, ELM or TET? Treatt has lower revenue, but higher earnings than Elementis. Elementis is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElementis£732.20M1.07-£34.70M-£0.04-3,310.00Treatt£143.55M2.14£11.31M£0.182,811.11 Is ELM or TET more profitable? Treatt has a net margin of 7.88% compared to Elementis' net margin of -5.22%. Treatt's return on equity of 8.46% beat Elementis' return on equity.Company Net Margins Return on Equity Return on Assets Elementis-5.22% -4.27% 4.49% Treatt 7.88%8.46%6.72% Is ELM or TET a better dividend stock? Elementis pays an annual dividend of GBX 3 per share and has a dividend yield of 2.3%. Treatt pays an annual dividend of GBX 8 per share and has a dividend yield of 1.6%. Elementis pays out -7,500.0% of its earnings in the form of a dividend. Treatt pays out 4,444.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Elementis is clearly the better dividend stock, given its higher yield and lower payout ratio. Do institutionals and insiders have more ownership in ELM or TET? 73.7% of Elementis shares are held by institutional investors. Comparatively, 50.9% of Treatt shares are held by institutional investors. 4.2% of Elementis shares are held by insiders. Comparatively, 13.4% of Treatt shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, ELM or TET? Elementis has a beta of 2.02, meaning that its stock price is 102% more volatile than the S&P 500. Comparatively, Treatt has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Does the media refer more to ELM or TET? In the previous week, Elementis had 4 more articles in the media than Treatt. MarketBeat recorded 4 mentions for Elementis and 0 mentions for Treatt. Treatt's average media sentiment score of 0.75 beat Elementis' score of 0.46 indicating that Treatt is being referred to more favorably in the news media. Company Overall Sentiment Elementis Neutral Treatt Positive Does the MarketBeat Community prefer ELM or TET? Elementis received 334 more outperform votes than Treatt when rated by MarketBeat users. However, 68.83% of users gave Treatt an outperform vote while only 65.73% of users gave Elementis an outperform vote. CompanyUnderperformOutperformElementisOutperform Votes49365.73% Underperform Votes25734.27% TreattOutperform Votes15968.83% Underperform Votes7231.17% Do analysts prefer ELM or TET? Elementis presently has a consensus price target of GBX 173.33, suggesting a potential upside of 30.92%. Treatt has a consensus price target of GBX 655, suggesting a potential upside of 29.45%. Given Elementis' higher possible upside, equities research analysts plainly believe Elementis is more favorable than Treatt.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elementis 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Treatt 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryTreatt beats Elementis on 10 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Treatt News Delivered to You Automatically Sign up to receive the latest news and ratings for TET and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TET vs. The Competition Export to ExcelMetricTreattSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£307.24M£9.19B£3.06B£1.62BDividend Yield1.84%3.47%5.11%10.98%P/E Ratio2,811.11304.90124.931,767.83Price / Sales2.14493.89543,793.77235,535.20Price / Cash165.4319.1023.8436.46Price / Book2.247.933.642.87Net Income£11.31M£144.05M£152.21M£145.83M7 Day Performance5.09%-1.99%-1.22%0.11%1 Month Performance15.39%-4.65%1.88%-0.11%1 Year Performance11.21%-3.05%32.81%15.63% Treatt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TETTreatt2.135 of 5 starsGBX 506+0.8%GBX 655+29.4%+12.2%£307.24M£143.55M2,811.11350Dividend IncreaseELMElementis2.7552 of 5 starsGBX 138.60+0.3%GBX 173.33+25.1%+11.2%£816.52M£732.20M-3,465.001,281News CoverageVCTVictrex2.5336 of 5 starsGBX 849-1.6%GBX 1,485+74.9%-36.0%£738.89M£284.10M2,425.711,109Dividend IncreaseGap DownESNTEssentra3.1423 of 5 starsGBX 148.60-3.4%GBX 216.67+45.8%-1.7%£426.69M£309.70M7,980.00350News CoverageGap UpSCPAScapa GroupN/AGBX 214.50flatN/A+0.0%£402.98M£281.80M-7.321,461SYNTSynthomer2.8889 of 5 starsGBX 171-3.5%GBX 288.33+68.6%-5.9%£279.71M£1.97B-280.334,200News CoverageZTFZotefoamsN/AGBX 358.96+0.3%N/A+26.5%£174.46M£133.40M1,794.80549Gap DownIOFIofinaN/AGBX 18.05+0.3%GBX 35+94.0%-9.5%£34.62M£51.71M1,804.5095Gap UpWCHWilmcote Holdings plc (WCH.L)N/AGBX 3flatN/A+0.0%£20.13MN/A-5.003ITXItaconixN/AGBX 112-4.7%N/A+0.4%£15.11M£6.62M-2,800.0017News CoverageGap UpHigh Trading VolumeDCTADirecta PlusN/AGBX 10.19-9.4%N/A-73.1%£10.64M£9.33M-169.83187Gap DownHigh Trading Volume Related Companies and Tools Related Companies ELM Competitors VCT Competitors ESNT Competitors SCPA Competitors SYNT Competitors ZTF Competitors IOF Competitors WCH Competitors ITX Competitors DCTA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TET) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treatt plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Treatt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.